Search Results - David Iser

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study by Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews

    Published in JHEP Reports (2023-10-01)
    Get full text
    Article


  2. 2

    High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study by Jasmine Yee, Joanne M. Carson, Behzad Hajarizadeh, Joshua Hanson, James O’Beirne, David Iser, Phillip Read, Anne Balcomb, Joseph S. Doyle, Jane Davies, Marianne Martinello, Philiipa Marks, Gregory J. Dore, Gail V. Matthews, the REACH‐C Study Group

    Published in Hepatology Communications (2022-03-01)
    Get full text
    Article


  3. 3

    Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol by Tim Spelman, David Iser, Margaret Hellard, Joseph Doyle, Louise Owen, Alexander Thompson, Fay H Johnston, Shannon Melody, N Scott, Mark A Stoové, A E Pedrana, Jacqui Richmond, Kate Turner, Tafireyi Marukutira, Karen P Moore, Wijnand Van Den Boom, Mark Veitch

    Published in BMJ Open (2022-03-01)
    Get full text
    Article


Search Tools: